Crystal M. North
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Crystal M. North has a total of 237 co-authors. Here are the top co-authors by number of shared publications:
David C. Christiani
Massachusetts General Hospital, Boston, MA, USA
6 shared publicationsBernard Kakuhikire
Mbarara University of Science and Technology Mbarara, Uganda
5 shared publicationsMark J. Siedner
Massachusetts General Hospital Boston, Massachusetts
5 shared publications- Mark Jacob Siedner
Africa Health Research Institute
5 shared publications - Alexander C. Tsai
Massachusetts General Hospital and Harvard Medical School
4 shared publications Alexander C. Tsai
Massachusetts General Hospital Boston, Massachusetts
3 shared publications
Latest Publications
- 3 November 2026
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
Advances in HIV-associated pulmonary diseases: an official American Thoracic Society workshop report
People with HIV (PWH) are at increased risk of a broad range of infectious and non-infectious pulmonary diseases. Since the last ATS Workshop on HIV-associated pulmonary disease, large national and international cohorts have demonstrated ongoing gaps in our understanding of lung disease in this vulnerable population that range from underappreciation of disease incidence and prevalence to lack of targeted treatments. Translational work on the underlying mechanisms of disease has demonstrated novel, HIV-specific mechanisms that may lend themselves to tailored therapies. Twenty-four experts in HIV-associated lung disease from across the translational spectrum were invited to participate in this ATS-sponsored Workshop utilizing a modified Delphi method that included a series of pre- and post-workshop electronic surveys and a two-day virtual workshop. Lung disease among PWH is driven by complex and interrelated mechanisms including persistent immune dysregulation, oxidative stress, accelerated aging, and microbiome alterations. Despite these advances in our understanding, important gaps persist between mechanistic insights and clinical care that include limited HIV-specific trials, underrepresentation of PWH in studies of lung disease, and the absence of tailored care strategies. These gaps are further accentuated by substantial variation in the availability of data from the most affected populations, particularly in sub-Saharan Africa and among children and adolescents. Overcoming these challenges will require coordinated, globally representative research efforts that leverage large cohorts, integrate multi-omics and longitudinal phenotyping, use mechanistic insights to inform clinical trials, and consider implementation science approaches with the ultimate goal of developing tailored prevention and treatment strategies for HIV-associated pulmonary diseases.
- 3 November 2026
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
Advances in HIV-associated pulmonary diseases: an official American Thoracic Society workshop report
People with HIV (PWH) are at increased risk of a broad range of infectious and non-infectious pulmonary diseases. Since the last ATS Workshop on HIV-associated pulmonary disease, large national and international cohorts have demonstrated ongoing gaps in our understanding of lung disease in this vulnerable population that range from underappreciation of disease incidence and prevalence to lack of targeted treatments. Translational work on the underlying mechanisms of disease has demonstrated novel, HIV-specific mechanisms that may lend themselves to tailored therapies. Twenty-four experts in HIV-associated lung disease from across the translational spectrum were invited to participate in this ATS-sponsored Workshop utilizing a modified Delphi method that included a series of pre- and post-workshop electronic surveys and a two-day virtual workshop. Lung disease among PWH is driven by complex and interrelated mechanisms including persistent immune dysregulation, oxidative stress, accelerated aging, and microbiome alterations. Despite these advances in our understanding, important gaps persist between mechanistic insights and clinical care that include limited HIV-specific trials, underrepresentation of PWH in studies of lung disease, and the absence of tailored care strategies. These gaps are further accentuated by substantial variation in the availability of data from the most affected populations, particularly in sub-Saharan Africa and among children and adolescents. Overcoming these challenges will require coordinated, globally representative research efforts that leverage large cohorts, integrate multi-omics and longitudinal phenotyping, use mechanistic insights to inform clinical trials, and consider implementation science approaches with the ultimate goal of developing tailored prevention and treatment strategies for HIV-associated pulmonary diseases.
- Open Access
- 16 September 2026
- Published by Oxford University Press (OUP) in ATS Scholar
Prioritizing Global Health Education in Pulmonary and Critical Care Fellowships: An Applicant Survey
Background: Global Health (GH) is expanding, offering an increasing number of opportunities for engagement to trainees in medical schools and residency programs. This expansion of opportunities has not yet reached those at the fellowship level, particularly in Critical Care Medicine (CCM), Pulmonary and Critical Care Medicine (PCCM), and Pulmonary Medicine (PM) fellowships (collectively termed PCCM). Objective: We surveyed applicants to US adult PCCM fellowship programs regarding interest in GH training and the influence of GH tracks and related opportunities on applicants’ rank list decisions. Methods: We developed a survey to assess applicants' demographics, prior GH experience, interest in pursuing GH experiences during and after fellowship, and preferences regarding GH opportunities within fellowship programs. Survey questions included multiple choice, Likert scale, and free text questions. After initial pilot testing, the survey was sent to 1,024 applicants applying to PCCM programs through the National Resident Matching Program match during the 2025 appointment year. Both univariate and multivariate regression models were built to identify predictors of GH interest. Results: Of the 325 applicants who completed the survey (31.7% response rate), 51% stated the GH was at least slightly important when ranking a given fellowship program. According to the surveyed applicants, the most important GH program elements were faculty mentors with GH experience within the division, opportunities for GH-related clinical service in the US, and established partnerships outside the US where fellows could rotate. Perceived barriers to a career in GH included lack of protected time for international work, family obligations, and lack of institutional funding. We also found a significant association on multivariate analysis between prior GH work and interest in pursuing it at the fellowship level (OR 2.76, 95% CI 1.04-5.49, p = 0.04). Conclusion: Applicants to US PCCM fellowship programs with prior GH experience are most likely to have a significant interest in pursuing GH work at the fellowship level. Important elements to a GH program within PCCM include faculty mentorship, opportunities for GH-related clinical service in the US, and established partnerships outside the US. Funding: MLS completed this work while supported on grant 5T32HL091816 from the National Heart, Lung, and Blood Institute.
- 16 September 2026
- Published by Oxford University Press (OUP) in ATS Scholar
Open AccessPrioritizing Global Health Education in Pulmonary and Critical Care Fellowships: An Applicant Survey
Background: Global Health (GH) is expanding, offering an increasing number of opportunities for engagement to trainees in medical schools and residency programs. This expansion of opportunities has not yet reached those at the fellowship level, particularly in Critical Care Medicine (CCM), Pulmonary and Critical Care Medicine (PCCM), and Pulmonary Medicine (PM) fellowships (collectively termed PCCM). Objective: We surveyed applicants to US adult PCCM fellowship programs regarding interest in GH training and the influence of GH tracks and related opportunities on applicants’ rank list decisions. Methods: We developed a survey to assess applicants' demographics, prior GH experience, interest in pursuing GH experiences during and after fellowship, and preferences regarding GH opportunities within fellowship programs. Survey questions included multiple choice, Likert scale, and free text questions. After initial pilot testing, the survey was sent to 1,024 applicants applying to PCCM programs through the National Resident Matching Program match during the 2025 appointment year. Both univariate and multivariate regression models were built to identify predictors of GH interest. Results: Of the 325 applicants who completed the survey (31.7% response rate), 51% stated the GH was at least slightly important when ranking a given fellowship program. According to the surveyed applicants, the most important GH program elements were faculty mentors with GH experience within the division, opportunities for GH-related clinical service in the US, and established partnerships outside the US where fellows could rotate. Perceived barriers to a career in GH included lack of protected time for international work, family obligations, and lack of institutional funding. We also found a significant association on multivariate analysis between prior GH work and interest in pursuing it at the fellowship level (OR 2.76, 95% CI 1.04-5.49, p = 0.04). Conclusion: Applicants to US PCCM fellowship programs with prior GH experience are most likely to have a significant interest in pursuing GH work at the fellowship level. Important elements to a GH program within PCCM include faculty mentorship, opportunities for GH-related clinical service in the US, and established partnerships outside the US. Funding: MLS completed this work while supported on grant 5T32HL091816 from the National Heart, Lung, and Blood Institute.
- Open Access
- 10 September 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
Potential risk factors for COPD exacerbations among a population of biomass-exposed people living in Uganda: a post hoc analysis
Extract Chronic obstructive pulmonary disease (COPD) exacerbations worsen lung function, increase mortality, and reduce quality of life. [1] Exacerbation frequency and risk factors are poorly described in low- and middle-income countries (LMICs), where 84% of COPD-related deaths occur [2].
- 10 September 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
Open AccessPotential risk factors for COPD exacerbations among a population of biomass-exposed people living in Uganda: a post hoc analysis
Extract Chronic obstructive pulmonary disease (COPD) exacerbations worsen lung function, increase mortality, and reduce quality of life. [1] Exacerbation frequency and risk factors are poorly described in low- and middle-income countries (LMICs), where 84% of COPD-related deaths occur [2].
- 16 February 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , 822-828
Time-Varying Associations Between Selected Clinical Indicators And In-Hospital Mortality During The Early Period Of Critical Care
BACKGROUND: Many patients in intensive care units (ICUs) are clinically unstable during the first several days of ICU care. The goal of this study was to describe how the association between selected clinical variables and in-hospital mortality varied across short, sequential time periods during the early phase of ICU care. METHODS: Retrospective analysis of 19,439 ICU encounters among 17,769 patients, aged 18 to 102, who were treated in three ICUs at a single academic medical center during the years 2018 to 2023. Each encounter was segmented into brief intervals of care defined by time between complete blood count results. We analyzed 144,157 time intervals representing the early period of care up to the first 20 consecutive time intervals. For each time interval, we performed multivariable logistic regression to estimate the odds ratios of association between nine selected clinical variables and in-hospital death. Variables included patient demographics, laboratory results, and treatment modalities previously found to be associated with ICU survival in published studies. Both current and previous exposure to life-support treatments (mechanical ventilation, pressors, or dialysis) and interactions among life-support treatments were also investigated as variables. RESULTS: The mean duration of the analyzed time intervals of care was 512 ±215 minutes (median 574, IQR 326–720 minutes). One third of in-hospital mortality among ICU patients occurred during the first 20 time intervals of care. The odds ratios for death for age, sex, platelet count, hemoglobin, and transfusion ranged from 1.01 to 1.35 with small variations across periods of care, whereas the odds ratios for ventilator use, dialysis, pressors, and bilirubin varied more widely from 1.43 to 4.75. CONCLUSION: The strength of association between selected clinical variables and in-hospital mortality varied with time during early periods of ICU care.
- 16 February 2026
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 143 (4) , 822-828
Time-Varying Associations Between Selected Clinical Indicators And In-Hospital Mortality During The Early Period Of Critical Care
BACKGROUND: Many patients in intensive care units (ICUs) are clinically unstable during the first several days of ICU care. The goal of this study was to describe how the association between selected clinical variables and in-hospital mortality varied across short, sequential time periods during the early phase of ICU care. METHODS: Retrospective analysis of 19,439 ICU encounters among 17,769 patients, aged 18 to 102, who were treated in three ICUs at a single academic medical center during the years 2018 to 2023. Each encounter was segmented into brief intervals of care defined by time between complete blood count results. We analyzed 144,157 time intervals representing the early period of care up to the first 20 consecutive time intervals. For each time interval, we performed multivariable logistic regression to estimate the odds ratios of association between nine selected clinical variables and in-hospital death. Variables included patient demographics, laboratory results, and treatment modalities previously found to be associated with ICU survival in published studies. Both current and previous exposure to life-support treatments (mechanical ventilation, pressors, or dialysis) and interactions among life-support treatments were also investigated as variables. RESULTS: The mean duration of the analyzed time intervals of care was 512 ±215 minutes (median 574, IQR 326–720 minutes). One third of in-hospital mortality among ICU patients occurred during the first 20 time intervals of care. The odds ratios for death for age, sex, platelet count, hemoglobin, and transfusion ranged from 1.01 to 1.35 with small variations across periods of care, whereas the odds ratios for ventilator use, dialysis, pressors, and bilirubin varied more widely from 1.43 to 4.75. CONCLUSION: The strength of association between selected clinical variables and in-hospital mortality varied with time during early periods of ICU care.
- 15 October 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (3) , 356-368
Personal PM2.5 exposure and lung function among adults with and without HIV who have recovered from pneumonia in Kampala, Uganda
Rationale: Air pollution and pneumonia are both associated with respiratory morbidity and disproportionately impact resource-limited settings. However, the impact of air pollution on lung health in these settings is incompletely understood. We characterized the relationship between personal PM2.5 exposure and lung function among adults who have recovered from pneumonia in Kampala, Uganda. Methods: Adults 18 to 60 years old who had recovered from pneumonia completed spirometry and diffusing capacity for carbon monoxide (DLco) testing following 48 hours of personal PM2.5 exposure measurement, between June 2021 and April 2023. We fit linear and logistic regression models to characterize the relationship between personal PM2.5 exposure and lung function. Models were adjusted for age, sex, smoking status, HIV, and socioeconomic status and were assessed for effect modification using interaction terms and stratified models. Results: Among 96 participants, the median age was 32.5 years, 48% were women, 53% were people with HIV, and 9% were diagnosed with chronic obstructive pulmonary disease (COPD). Median personal PM2.5 exposure was 67 µg/m3, although 67% of participants reported their home air quality as excellent or good. Personal PM2.5 exposure did not differ by sex, HIV serostatus, or type of pneumonia. In adjusted models, a 1-µg/m3 increase in PM2.5 was associated with decreased forced expiratory volume in 1 second (β = –3.16; 95% CI, –5.59 to –0.74), forced vital capacity (β = –3.09; 95% CI, –5.51 to –0.66), and DLco (β = –0.04; 95% CI, –0.06 to –0.02) and with increased odds of COPD (adjusted odds ratio, 1.01; 95% CI, 1.00 to 1.02). There was no evidence of effect modification by sex, HIV, tuberculosis pneumonia, or socioeconomic status. Conclusion: Among adults who had recovered from pneumonia in Kampala, PM2.5 was associated with reduced lung function, highlighting the importance of air pollution exposure mitigation in improving chronic lung health among vulnerable populations in resource-limited settings. Future work must differentiate PM2.5 sources in these settings to inform regionally appropriate mitigation efforts.
- 15 October 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (3) , 356-368
Personal PM2.5 exposure and lung function among adults with and without HIV who have recovered from pneumonia in Kampala, Uganda
Rationale: Air pollution and pneumonia are both associated with respiratory morbidity and disproportionately impact resource-limited settings. However, the impact of air pollution on lung health in these settings is incompletely understood. We characterized the relationship between personal PM2.5 exposure and lung function among adults who have recovered from pneumonia in Kampala, Uganda. Methods: Adults 18 to 60 years old who had recovered from pneumonia completed spirometry and diffusing capacity for carbon monoxide (DLco) testing following 48 hours of personal PM2.5 exposure measurement, between June 2021 and April 2023. We fit linear and logistic regression models to characterize the relationship between personal PM2.5 exposure and lung function. Models were adjusted for age, sex, smoking status, HIV, and socioeconomic status and were assessed for effect modification using interaction terms and stratified models. Results: Among 96 participants, the median age was 32.5 years, 48% were women, 53% were people with HIV, and 9% were diagnosed with chronic obstructive pulmonary disease (COPD). Median personal PM2.5 exposure was 67 µg/m3, although 67% of participants reported their home air quality as excellent or good. Personal PM2.5 exposure did not differ by sex, HIV serostatus, or type of pneumonia. In adjusted models, a 1-µg/m3 increase in PM2.5 was associated with decreased forced expiratory volume in 1 second (β = –3.16; 95% CI, –5.59 to –0.74), forced vital capacity (β = –3.09; 95% CI, –5.51 to –0.66), and DLco (β = –0.04; 95% CI, –0.06 to –0.02) and with increased odds of COPD (adjusted odds ratio, 1.01; 95% CI, 1.00 to 1.02). There was no evidence of effect modification by sex, HIV, tuberculosis pneumonia, or socioeconomic status. Conclusion: Among adults who had recovered from pneumonia in Kampala, PM2.5 was associated with reduced lung function, highlighting the importance of air pollution exposure mitigation in improving chronic lung health among vulnerable populations in resource-limited settings. Future work must differentiate PM2.5 sources in these settings to inform regionally appropriate mitigation efforts.
- Open Access
Impact of Meteorological Factors on Seasonal and Diurnal Variation of PM2.5 at a Site in Mbarara, Uganda
Because PM2.5 concentrations are not regularly monitored in Mbarara, Uganda, this study was implemented to test whether correlations exist between weather parameters and PM2.5 concentration, which could then be used to estimate PM2.5 concentrations. PM2.5 was monitored for 24 h periods once every week for eight months, while weather parameters were monitored every day. The mean dry and wet season PM2.5 concentrations were 70.1 and 39.4 µg/m3, respectively. Diurnal trends for PM2.5 levels show bimodal peaks in the morning and evening. The univariate regression analysis between PM2.5 and meteorological factors for the 24 h averages yields a significant correlation with air pressure when all data are considered, and when the data are separated by season, there is a significant correlation between PM2.5 concentration and wind speed in the dry season. A strong correlation is seen between diurnal variations in PM2.5 concentration and most weather parameters, but our analysis suggests that in modeling PM2.5 concentrations, the importance of these meteorological factors is mainly due to their correlation with underlying causes including diurnal changes in the atmospheric boundary layer height and changes in sources both hourly and seasonally. While additional measurements are needed to confirm the results, this study contributes to the knowledge of short-term and seasonal variation in PM2.5 concentration in Mbarara and forms a basis for modeling short-term variation in PM2.5 concentration and determining the effect of seasonal and diurnal sources on PM2.5 concentration.
Open AccessImpact of Meteorological Factors on Seasonal and Diurnal Variation of PM2.5 at a Site in Mbarara, Uganda
Because PM2.5 concentrations are not regularly monitored in Mbarara, Uganda, this study was implemented to test whether correlations exist between weather parameters and PM2.5 concentration, which could then be used to estimate PM2.5 concentrations. PM2.5 was monitored for 24 h periods once every week for eight months, while weather parameters were monitored every day. The mean dry and wet season PM2.5 concentrations were 70.1 and 39.4 µg/m3, respectively. Diurnal trends for PM2.5 levels show bimodal peaks in the morning and evening. The univariate regression analysis between PM2.5 and meteorological factors for the 24 h averages yields a significant correlation with air pressure when all data are considered, and when the data are separated by season, there is a significant correlation between PM2.5 concentration and wind speed in the dry season. A strong correlation is seen between diurnal variations in PM2.5 concentration and most weather parameters, but our analysis suggests that in modeling PM2.5 concentrations, the importance of these meteorological factors is mainly due to their correlation with underlying causes including diurnal changes in the atmospheric boundary layer height and changes in sources both hourly and seasonally. While additional measurements are needed to confirm the results, this study contributes to the knowledge of short-term and seasonal variation in PM2.5 concentration in Mbarara and forms a basis for modeling short-term variation in PM2.5 concentration and determining the effect of seasonal and diurnal sources on PM2.5 concentration.
- Open Access
- 1 January 2024
- Published by Springer Nature in Aerosol and Air Quality Research
- Vol. 24 (4) , 230203
Ambient PM2.5 Temporal Variation and Source Apportionment in Mbarara, Uganda
Air pollution is the leading environmental cause of death globally, and most mortality occurs in resource-limited settings such as sub-Saharan Africa. The African continent experiences some of the worst ambient air pollution in the world, yet there are relatively little African data characterizing ambient pollutant levels and source admixtures. In Uganda, ambient PM2.5 levels exceed international health standards. However, most studies focus only on urban environments and do not characterize pollutant sources. We measured daily ambient PM2.5 concentrations and sources in Mbarara, Uganda from May 2018 through February 2019 using Harvard impactors fitted with size-selective inlets. We compared our estimates to publicly available levels in Kampala, and to World Health Organization (WHO) air quality guidelines. We characterized the leading PM2.5 sources in Mbarara using x-ray fluorescence and positive matrix factorization. Daily PM2.5 concentrations were 26.7 µg m–3 and 59.4 µg m–3 in Mbarara and Kampala, respectively (p < 0.001). PM2.5 concentrations exceeded WHO guidelines on 58% of days in Mbarara and 99% of days in Kampala. In Mbarara, PM2.5 was higher in the dry as compared to the rainy season (30.8 vs. 21.3, p < 0.001), while seasonal variation was not observed in Kampala. PM2.5 concentrations did not vary on weekdays versus weekends in either city. In Mbarara, the six main ambient PM2.5 sources identified included (in order of abundance): traffic-related, biomass and secondary aerosols, industry and metallurgy, heavy oil and fuel combustion, fine soil, and salt aerosol. Our findings confirm that air quality in southwestern Uganda is unsafe and that mitigation efforts are urgently needed. Ongoing work focused on improving air quality in the region may have the greatest impact if focused on traffic and biomass-related sources.
- 1 January 2024
- Published by Springer Nature in Aerosol and Air Quality Research
- Vol. 24 (4) , 230203
Open AccessAmbient PM2.5 Temporal Variation and Source Apportionment in Mbarara, Uganda
Air pollution is the leading environmental cause of death globally, and most mortality occurs in resource-limited settings such as sub-Saharan Africa. The African continent experiences some of the worst ambient air pollution in the world, yet there are relatively little African data characterizing ambient pollutant levels and source admixtures. In Uganda, ambient PM2.5 levels exceed international health standards. However, most studies focus only on urban environments and do not characterize pollutant sources. We measured daily ambient PM2.5 concentrations and sources in Mbarara, Uganda from May 2018 through February 2019 using Harvard impactors fitted with size-selective inlets. We compared our estimates to publicly available levels in Kampala, and to World Health Organization (WHO) air quality guidelines. We characterized the leading PM2.5 sources in Mbarara using x-ray fluorescence and positive matrix factorization. Daily PM2.5 concentrations were 26.7 µg m–3 and 59.4 µg m–3 in Mbarara and Kampala, respectively (p < 0.001). PM2.5 concentrations exceeded WHO guidelines on 58% of days in Mbarara and 99% of days in Kampala. In Mbarara, PM2.5 was higher in the dry as compared to the rainy season (30.8 vs. 21.3, p < 0.001), while seasonal variation was not observed in Kampala. PM2.5 concentrations did not vary on weekdays versus weekends in either city. In Mbarara, the six main ambient PM2.5 sources identified included (in order of abundance): traffic-related, biomass and secondary aerosols, industry and metallurgy, heavy oil and fuel combustion, fine soil, and salt aerosol. Our findings confirm that air quality in southwestern Uganda is unsafe and that mitigation efforts are urgently needed. Ongoing work focused on improving air quality in the region may have the greatest impact if focused on traffic and biomass-related sources.
- Open Access
- 1 January 2024
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 209 (1) , 16-18
Walking the Tightrope: Characterizing Acute Respiratory Distress Syndrome in Resource- and Data-constrained Settings
- 1 January 2024
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 209 (1) , 16-18
Open AccessWalking the Tightrope: Characterizing Acute Respiratory Distress Syndrome in Resource- and Data-constrained Settings
- 22 August 2023
- Published by Wiley in Transfusion
- Vol. 63 (9) , 1661-1676
Platelet transfusion in critical care: A new method to analyze transfusion practice based on decision time intervals
Background: While prior studies of platelet transfusion in critical care have focused on transfusions given, proper analysis of clinical transfusion practice also requires consideration of the decision not to transfuse.Study Design and Methods: We introduce a new method to assess transfusion practice based on decision time intervals (DTIs). Each patient's intensive care (ICU) stay was segmented into a series of DTIs defined by a time interval following results of a complete blood count (CBC). We studied the presence of 17 clinical factors during each DTI whether transfusion was given or not. We used a generalized linear mixed model to assess the most influential clinical triggers for platelet transfusion.Results: Among 6125 ICU patients treated between October 2016 and October 2021, we analyzed 39,745 DTIs among patients (n = 2921) who had at least one DTI with thrombocytopenia (≤150,000/μL). We found no association between platelet count and two markers of bleeding: drop in hemoglobin and chest tube drainage. We found that the majority of DTIs were associated with no platelet transfusion regardless of the platelet count; that no specific platelet value triggered transfusion; but rather that multiple clinical factors in conjunction with the platelet count influenced the decision to transfuse.Discussion: DTI analysis represents a new method to assess transfusion practice that considers both transfusions given and not given, and that analyzes clinical circumstances present when decisions regarding transfusion are made. The method is easily adapted to blood components other than platelet transfusions and is easily extended to other ICU and other hospital settings.
- 22 August 2023
- Published by Wiley in Transfusion
- Vol. 63 (9) , 1661-1676
Platelet transfusion in critical care: A new method to analyze transfusion practice based on decision time intervals
Background: While prior studies of platelet transfusion in critical care have focused on transfusions given, proper analysis of clinical transfusion practice also requires consideration of the decision not to transfuse.Study Design and Methods: We introduce a new method to assess transfusion practice based on decision time intervals (DTIs). Each patient's intensive care (ICU) stay was segmented into a series of DTIs defined by a time interval following results of a complete blood count (CBC). We studied the presence of 17 clinical factors during each DTI whether transfusion was given or not. We used a generalized linear mixed model to assess the most influential clinical triggers for platelet transfusion.Results: Among 6125 ICU patients treated between October 2016 and October 2021, we analyzed 39,745 DTIs among patients (n = 2921) who had at least one DTI with thrombocytopenia (≤150,000/μL). We found no association between platelet count and two markers of bleeding: drop in hemoglobin and chest tube drainage. We found that the majority of DTIs were associated with no platelet transfusion regardless of the platelet count; that no specific platelet value triggered transfusion; but rather that multiple clinical factors in conjunction with the platelet count influenced the decision to transfuse.Discussion: DTI analysis represents a new method to assess transfusion practice that considers both transfusions given and not given, and that analyzes clinical circumstances present when decisions regarding transfusion are made. The method is easily adapted to blood components other than platelet transfusions and is easily extended to other ICU and other hospital settings.
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A4513
Characterizing Lung Function Trajectory in a Cohort of Adults in Rural Uganda
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A4513
Characterizing Lung Function Trajectory in a Cohort of Adults in Rural Uganda